Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2026)
Collegium Pharmaceutical's Convertible Debt was $238.73 million in Q2 2026, up 0.4% from $237.69 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Convertible Debt at Collegium Pharmaceutical came in at $238.21 million, up 0.4% from FY2024.
- Convertible Debt shows a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- In earlier years, Convertible Debt was $237.17 million in FY2024 (-9.5%), $262.13 million in FY2023 (+86.1%), $140.87 million in FY2022 (+0.6%) and $139.97 million in FY2021 (+40.6%).
- The Q2 2026 figure marks the highest quarterly Convertible Debt since Q1 2024.
- Compared with a year earlier, Convertible Debt has increased for five straight quarters, with an average decline of 3.3% over the last eight quarters.
- The best year-over-year quarter for Convertible Debt over five years was Q1 2023 (growth of 86.3%); the worst was Q1 2025 (a decline of 9.5%).
- Per Business Quant data, COLL's Convertible Debt in the three quarters before Q2 2026 was $238.47 million (Q1 2026), $238.21 million (Q4 2025) and $237.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 238.73 Mn |
| Mar 31, 2026 | 238.47 Mn |
| Dec 31, 2025 | 238.21 Mn |
| Sep 30, 2025 | 237.95 Mn |
| Jun 30, 2025 | 237.69 Mn |
| Mar 31, 2025 | 237.43 Mn |
| Dec 31, 2024 | 237.17 Mn |
| Sep 30, 2024 | 236.91 Mn |
| Jun 30, 2024 | 236.65 Mn |
| Mar 31, 2024 | 262.43 Mn |
| Dec 31, 2023 | 262.13 Mn |
| Sep 30, 2023 | 261.82 Mn |
| Jun 30, 2023 | 261.52 Mn |
| Mar 31, 2023 | 261.22 Mn |
| Dec 31, 2022 | 140.87 Mn |
| Sep 30, 2022 | 140.64 Mn |
| Jun 30, 2022 | 140.42 Mn |
| Mar 31, 2022 | 140.19 Mn |
| Dec 31, 2021 | 139.97 Mn |
| Sep 30, 2021 | 139.74 Mn |
API Access
Collegium Pharmaceutical Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();